Isopentenyladenosine,
N(6)-(delta(2)-Isopentenyl)Adenosine,
Riboprine,
7724-76-7,
N6-(3-Methyl-2-butenyl)adenosine,
Isopentenyladenosine,
2iPA,
N6-(2-Isopentenyl)adenosine,
Isopentenyladenosine riboside,
Riboprina,
Riboprinum,
6-(gamma,gamma-Dimethylallylamino)purine riboside,
2-IPA,
ADENOSINE, N-(3-METHYL-2-BUTENYL)-,
Isopentenyl adenine riboside,
6-(3-Methyl-2-butenylamino)purine riboside,
Riboprine [USAN:INN],
Riboprinum [INN-Latin],
N-(3-Methyl-2-butenyl)adenosine,
Riboprina [INN-Spanish],
UNII-8EU82FAZ5J,
Dimethylallyladenosine,
N-(3-methylbut-2-en-1-yl)adenosine,
N-Isopentenyladenosine,
Isopentenyl adenosine,
N(sup 6)-Isopentenyladenosine,
N(sup 6)-Dimethylallyladenosine,
SQ 22558,
ZK 20 242,
EINECS 231-771-3,
N(sup 6)-(2-Isopentenyl)adenosine,
NSC 105546,
8EU82FAZ5J,
N(6)-(2-isopentenyl)adenosine,
CHEBI:62881,
N(sup 6)-(delta(sup 2)-Isopentenyl)adenosine,
N-(3-methylbut-2-enyl)adenosine,
C15H21N5O4,
N(6)-(3-methyl-2-butenyl)adenosine,
N(6)-(Delta(2)-isopentenyl)adenosine,
6-N-((3-Methyl-2-butenyl)amino)-9beta-D-ribofuranosylpurine,
9beta-D-Ribofuranosyl-9H-purine, N-(3-methyl-2-butenylamino)-,
6-N-((3-Methyl-2-butenyl)amino)-9-beta-D-ribofuranosyl-9H-purine,
i6a,
Riboprin,
2iP Riboside,
NSC-105546,
Riboprine (USAN/INN),
AC1L2NEW,
N6-Dimethylallyladenosine,
Au(2) IUUO,
6-(3,3-Dimethylallylamino)-9-(b-D-ribofuranosyl)purine,
SCHEMBL4599,
DSSTox_CID_31617,
DSSTox_RID_97501,
DSSTox_GSID_57828,
6-N-((3-Methyl-2-butenyl)amino)-9.beta.-D-ribofuranosylpurine,
CHEMBL452867,
6-N-((3-Methyl-2-butenyl)amino)-9-.beta.-D-ribofuranosyl-9H-purine,
DTXSID1057828,
ZINC57125,
N6-(2-OiIiI(c)>>u)IUUO,
N6-(delta2-Isopentenyl)adenosine,
USVMJSALORZVDV-SDBHATRESA-N,
EBD80372,
N-6-(delta-2-Isopentenyl)adenosine,
Tox21_113776,
2058AC,
MFCD00005741,
AKOS016009606,
CS-W011925,
DB11933,
DS-5147,
SB19217,
NCGC00253650-01,
AJ-09596,
LS-15154,
ZB001990,
CAS-7724-76-7,
N6-(.DELTA.2-Isopentenyl)adenine riboside,
FT-0636577,
N6-(.gamma.,.gamma.-Dimethylallyl)adenosine,
33156-15-9,
C16427,
D05726,
724G767,
SR-01000883994,
SR-01000883994-1,
N6-(|A,|A- paragraph signthorn(1/4)x>>uI(c)+/-u>>u)IUUO,
6-(3,3- paragraph signthorn(1/4)x>>uI(c)+/-u>>u degrees +/->>u)aNssE masculineEUO,
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(3-methylbut-2-enylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol,
N6-Isopentenyladenosine,
N6-ISOPENTENYLADENOSINE-D6,
CID24405,
N6-(.DELTA.2-Isopentenyl)adenosine,
C15-H21-N5-O4,
SQ 22,558,
ipa,
6-(.gamma.,.gamma.-Dimethylallylamino)purine riboside,
9.beta.-D-Ribofuranosyl-9H-purine, N-(3-methyl-2-butenylamino)-,
6-(3,3-Dimethylallylamino)-9-(beta-D-ribofuranosyl)purine, 98% - 25MG 25mg,
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(3-methylbut-2-enylamino)purin-9-yl]oxolane-3,4-diol,
2365-40-4,
ZIR,